PEAK6 Investments’s Cantel Medical Corporation CMD Stock Holding History

PEAK6 Investments’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-8,000	Closed	-$639K	–	6135
2021 Q1	$639K	Sell	8,000 -9,100	-53%	-$711K	﹤0.01%	2963
2020 Q4	$1.35M	Sell	17,100 -10,600	-38%	-$622K	﹤0.01%	2198
2020 Q3	$1.22M	Buy	27,700 +10,900	+65%	+$537K	﹤0.01%	2101
2020 Q2	$743K	Buy	16,800 +1,500	+10%	+$56K	﹤0.01%	2346
2020 Q1	$549K	Buy	+15,300	New	+$870K	﹤0.01%	2008
2019 Q4	–	Sell	-12,100	Closed	-$905K	–	4316
2019 Q3	$905K	Buy	+12,100	New	+$1.03M	0.01%	1842
2018 Q4	–	Sell	-100	Closed	-$9K	–	4961
2018 Q3	$9K	Buy	+100	New	+$9.53K	﹤0.01%	3973

PEAK6 Investments's CMD Position: Q2 2021 in Review

PEAK6 Investments sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 1,507 shares — an estimated $120K sold.

PEAK6 Investments first reported a position in CMD in Q3 2018 and held it in 7 quarters. The position peaked at $1.94M in Q2 2019. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

PEAK6 Investments reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
PEAK6 Investments sold 1,507 Cantel Medical Corporation shares in Q2 2021, an estimated $120K.
PEAK6 Investments first reported a position in Cantel Medical Corporation in Q3 2018 and held it in 7 quarters.
PEAK6 Investments's Cantel Medical Corporation position peaked at $1.94M in Q2 2019.
0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on PEAK6 Investments's 13F filing for Q2 2021, filed 13 Aug 2021.